These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 21117302

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R, Keleştimur F, Unlühizarci K, Bayram F, Sahin Y, Tutuş A.
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T, Smith KA, Coady AM, Kilpatrick ES, Atkin SL.
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [Abstract] [Full Text] [Related]

  • 5. Clinical observations and hormone screenings of patients with non-standard hypertrophy of the adrenal cortex.
    Franik G, Skałba P.
    Endokrynol Pol; 2011 Jan; 62(3):230-7. PubMed ID: 21717405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS, Cartes A, Maliqueo M, Vantman D, Gutiérrez C, Toloza H, Echiburú B, Recabarren SE.
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [Abstract] [Full Text] [Related]

  • 8. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M, Azziz R, Beires J, Pignatelli D.
    Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
    [Abstract] [Full Text] [Related]

  • 9. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A.
    Endokrynol Pol; 2011 Jul; 62(2):120-8. PubMed ID: 21528473
    [Abstract] [Full Text] [Related]

  • 10. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [Abstract] [Full Text] [Related]

  • 11. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
    Erel CT, Senturk LM, Oral E, Colgar U, Ertungealp E.
    Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
    [Abstract] [Full Text] [Related]

  • 12. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
    Keefe CC, Goldman MM, Zhang K, Clarke N, Reitz RE, Welt CK.
    PLoS One; 2014 Jul; 9(4):e93805. PubMed ID: 24713888
    [Abstract] [Full Text] [Related]

  • 15. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
    Cinar N, Cetinozman F, Aksoy DY, Elcin G, Yildiz BO.
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
    [Abstract] [Full Text] [Related]

  • 16. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL, McLachlan RI.
    Hum Reprod; 1995 Mar; 10(3):513-9. PubMed ID: 7782424
    [Abstract] [Full Text] [Related]

  • 17. Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome.
    Fruzzetti F, De Lorenzo D, Ricci C, Teti G.
    Fertil Steril; 1995 Apr; 63(4):734-41. PubMed ID: 7890056
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Apr; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 19. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
    Abbott DH, Rayome BH, Dumesic DA, Lewis KC, Edwards AK, Wallen K, Wilson ME, Appt SE, Levine JE.
    Hum Reprod; 2017 Apr 01; 32(4):923-936. PubMed ID: 28333238
    [Abstract] [Full Text] [Related]

  • 20. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E, Schwetz V, Giuliani A, Pieber TR, Obermayer-Pietsch B.
    Fertil Steril; 2012 Nov 01; 98(5):1318-25.e1. PubMed ID: 22835450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.